.On the heels of an FDA turndown for its own primary competing Novo Nordisk, Eli Lilly is actually p...
.Merely a couple of months after dosing the very first person in a period 2 trial for recently detec...
.Eli Lilly's look for being overweight targets has led it to the black genome. The Big Pharma has ac...
.Toolbox Biosciences is proceeding up. The tissue therapy business has added on $325 thousand in amm...
.After raising $170 thousand back in February, metabolic disease-focused BioAge Labs has filed to de...
.Aelis Farma's chances of protecting an easy, good selection on a $100 thousand alternative settleme...
.ProKidney has quit some of a set of phase 3 tests for its cell treatment for renal condition after ...
.Vaxcyte unveiled what professionals named "remarkable" period 1/2 information for its own 31-valent...
.Recursion has actually stumbled through an early examination of its tech-enabled method to medicati...
.Phone it a situation of really good chemical make up: Acepodia, a biotech based upon Nobel Champion...